This year’s Conference on Retroviruses and Opportunistic Infections (CROI) features several sessions discussing prevention ...

Patients who struggle to take daily HIV pills can benefit from long-acting injectable treatments, a new study by researchers ...

As of February 2025, the HIV programmes in Ukraine are facing several challenges and risks: ...

The major backer of the lenacapavir roll-out is assuring nervous researchers that they will keep their part of funding promises. It's a good economic investment, says the Fund's Peter Sands, into a ...